Drug Patents owned by Life Molecular

1. Drug name - NEURACEQ

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US7807135 LIFE MOLECULAR Stilbene derivatives and their use for binding and imaging amyloid plaques
Mar, 2029

(6 years from now)

CN101123995A LIFE MOLECULAR Stilbene Derivate And Thereof Use For Combining And Imaging Amyloid Plaque
Dec, 2025

(3 years from now)

CN101123995B LIFE MOLECULAR Stilbene Derivatives And Their Use For Binding And Imaging Amyloid Plaques
Dec, 2025

(3 years from now)

IN283158B LIFE MOLECULAR Stilbene Derivatives And Their Use For Binding And Imaging Amyloid Plaques
Dec, 2025

(3 years from now)

IN200704878P1 LIFE MOLECULAR Stilbene Derivatives And Their Use For Binding Andimaging Amyloid Plaques
Dec, 2025

(3 years from now)

EP2213652B1 LIFE MOLECULAR Stilbene Derivatives And Their Use For Binding And Imaging Amyloid Plaques
Feb, 2029

(6 years from now)

EP2213652A1 LIFE MOLECULAR Stilbene Derivatives And Their Use For Binding And Imaging Amyloid Plaques
Feb, 2029

(6 years from now)

Drugs and Companies using FLORBETABEN F-18 ingredient

Treatment: NA

Dosage: SOLUTION;INTRAVENOUS

More Information on Dosage
Strength Dosage Availability
30ML (1.4-135mCi/ML) SOLUTION;INTRAVENOUS Prescription

availability in other generic markets.

Click on the highlighted region to filter.